Softwr

Healthcare · head to head

Ambra Health vs Clue

Ambra Health logo

Ambra Health

Healthcare

Cloud medical image exchange and vendor neutral archive, now part of Intelerad

From
On request
Rated
-
Clue logo

Clue

Healthcare

Period and cycle tracking app owned by German company Biowink, positioned around science based tracking and a published stance against sharing data with law enforcement

From
Free
Rated
-

The short version

  • Only Clue has a free tier, so it costs nothing to try first.
  • Each has a real cost: Ambra Health intelerad now owns Ambra and ambrahealth.com redirects to Intelerad client support, so a buyer is committing to the Intelerad portfolio roadmap and should get written positioning on Ambra versus Intelerad own cloud PACS before signing.; Clue clues stated policy on not sharing data with law enforcement without a valid legal process is the companys own published position and legal interpretation, not an independent guarantee, and it can still be compelled to comply with a legally binding request under EU or other applicable law.
  • They diverge on capability: Ambra Health covers Image exchange, Clue covers Cycle and symptom tracking.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Ambra Health and Clue actually diverge.

Attributes where Ambra Health and Clue differ
AttributeAmbra HealthClue
Starting priceOn requestFree
Pricing modelquoteFree with a Plus subscription
Free tierNoYes
PlatformsWeb, iOS, AndroidiOS, Android

Identical on both: user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Ambra Health

  • Image exchange
  • Cloud VNA
  • Zero footprint viewer
  • Patient upload portal
  • Identity reconciliation
  • Clinical trials workflow
  • API and HL7 integration

Only in Clue

  • Cycle and symptom tracking
  • Cycle insights and patterns
  • Research partnerships
  • EU-based data hosting
  • Fertility and conception mode
  • Perimenopause and other life stage tracking

What people use each for

The jobs each tool is most often brought in to do.

Ambra Health

  • A trauma centre that receives transfers from regional hospitals and needs outside CT studies readable before the patient arrives, not after a disc is walked innot Clue
  • An oncology programme collecting outside imaging for multidisciplinary tumour board review from dozens of referring practicesnot Clue
  • A clinical research organisation routing de identified trial imaging from many sites to one central reading facilitynot Clue
  • A health system trying to eliminate the CD import desk by giving patients and referring practices a direct upload portalnot Clue

Clue

  • Someone specifically weighing data jurisdiction and legal exposure when choosing a period tracking app, given Clues EU basis and published stance on law enforcement requestsnot Ambra Health
  • A user who wants cycle tracking positioned around scientific research partnerships rather than lifestyle or community contentnot Ambra Health
  • A buyer comparing Clue directly against Flo on current published privacy policy language before choosing which app to trustnot Ambra Health
  • Someone tracking perimenopause or other non-standard cycle stages that some period apps do not support wellnot Ambra Health

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Ambra Health

  • Intelerad now owns Ambra and ambrahealth.com redirects to Intelerad client support, so a buyer is committing to the Intelerad portfolio roadmap and should get written positioning on Ambra versus Intelerad own cloud PACS before signing.
  • Ambra is built for cross organisation exchange, not for high volume in department diagnostic reading, so a radiology group that expects it to replace a departmental PACS finds the reading ergonomics and hanging protocols thinner than a dedicated PACS client.
  • Pricing scales with study volume and stored capacity, so a health system that turns on patient upload broadly sees storage grow from low value outside studies it never intended to retain, and the renewal reflects that.
  • Identity reconciliation of studies arriving with foreign patient identifiers still needs human review at volume, and sites that budget for zero touch matching end up staffing an imaging records queue.
  • Adoption depends on referring practices actually using the portal, and the vendor cannot make that happen, so image exchange projects frequently stall at the outreach and change management step rather than at the technology.

Clue

  • Clues stated policy on not sharing data with law enforcement without a valid legal process is the companys own published position and legal interpretation, not an independent guarantee, and it can still be compelled to comply with a legally binding request under EU or other applicable law.
  • Deeper cycle insights and predictions, the features most likely to justify tracking in the first place, are gated behind the Clue Plus subscription rather than fully free.
  • Being a smaller company than some competitors, Clue has less capital and legal resource to contest large-scale legal requests than a larger, better-funded rival might, despite its stated intent to do so.
  • Research partnerships using anonymised user data, while opt-in, still mean user-derived data can be used in ways beyond direct app functionality, and users should check current consent settings.
  • Cycle predictions rely on self-reported data and general population models, so accuracy for irregular cycles or specific medical conditions remains limited regardless of which app is used.

Pricing, plan by plan

Ambra Health

On request
  • Ambra Health$undefined/year
    • Priced by annual study volume and stored capacity
    • Exchange partner connections and upload portals scoped per deployment
    • Zero footprint viewer licensed with the platform

Clue

Free
  • Clue Plus$9.99/month
    • Free tier covers core cycle tracking, logging and basic predictions
    • Clue Plus adds deeper cycle insights, extended predictions and personalised content
    • Annual Plus plans typically offered at a lower effective monthly rate

Which should you pick?

Choose Ambra Health if

  • You need image exchange.
  • You work on Web, iOS, Android.
  • You also want cloud vna.

Choose Clue if

  • You need cycle and symptom tracking.
  • You want to start without paying.
  • You work on iOS, Android.
  • You also want cycle insights and patterns.

Questions people ask

Is Ambra Health or Clue better?
Neither clearly leads. Ambra Health starts at On request and Clue at Free, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Ambra Health or Clue?
Clue has a free tier; the other does not. Paid plans start at On request for Ambra Health and Free for Clue.
Does Ambra Health or Clue run on more platforms?
Ambra Health runs on Web, iOS, Android. Clue runs on iOS, Android.
Can I use Clue for free?
Yes. Clue has a free tier, so you can try it without paying. Ambra Health starts at On request.
What is Ambra Health best used for?
Ambra Health is most often used for a trauma centre that receives transfers from regional hospitals and needs outside ct studies readable before the patient arrives, not after a disc is walked in, an oncology programme collecting outside imaging for multidisciplinary tumour board review from dozens of referring practices, a clinical research organisation routing de identified trial imaging from many sites to one central reading facility, a health system trying to eliminate the cd import desk by giving patients and referring practices a direct upload portal. Of those, a trauma centre that receives transfers from regional hospitals and needs outside ct studies readable before the patient arrives, not after a disc is walked in and an oncology programme collecting outside imaging for multidisciplinary tumour board review from dozens of referring practices are not what Clue is typically brought in for.
What can Ambra Health do that Clue cannot?
Ambra Health covers Image exchange, Cloud VNA, Zero footprint viewer, Patient upload portal. Clue covers Cycle and symptom tracking, Cycle insights and patterns, Research partnerships, EU-based data hosting.

Answered from the vendors’ own pages

Ambra Health: Is Ambra Health still sold under its own name?

Yes. Intelerad still markets Ambra Health as a named product line, but the standalone website redirects to Intelerad, and support and contracting run through Intelerad.

Clue: Does Clue share data with law enforcement?

Clue publishes a policy stating it does not share health data with law enforcement or public authorities without a legally binding request and states it will challenge requests it considers improper. This is the companys stated position; verify the current policy directly for specifics.

Ambra Health: Can Ambra replace our PACS?

For image exchange, archiving and clinical viewing, yes. For high volume diagnostic radiology reading it is generally deployed alongside a departmental PACS rather than instead of one.

Clue: Why does Clue emphasise being an EU company?

Clue operates under EU GDPR data protection rules and states this legal basis makes it harder for authorities outside the EU, including US authorities, to compel data disclosure than for a company based in the US.

Ambra Health: Is pricing published?

No. It is quoted by annual study volume, stored capacity and the scope of exchange connections.

Clue: Is Clue free?

Core cycle tracking, logging and basic predictions are free. Deeper insights and extended predictions require Clue Plus.

Ambra Health: Does the viewer require software on referring physician machines?

No. The viewer is zero footprint HTML5, which is the main reason referring practices adopt it at all.

Share

Related pages

Other head to heads